法學期刊.
  • 社群分享
論著名稱: 人獸混合胚胎的研究正當性與可專利性之現在與未來
編著譯者: 王服清
出版日期: 2009.06
刊登出處: 台灣/法學新論第 11 期 /29-66 頁
頁  數: 36 點閱次數: 819
下載點數: 144 點 銷售明細: 權利金查詢 變更售價
授 權 者: 王服清
關 鍵 詞: 嵌合體複製技術人獸胚胎胚胎幹細胞公序良俗
中文摘要: 「凱美拉」(Chimeras)——嵌合體——出自希臘神話,是不同物種的混合體之代名詞。由於目前胚胎學、複製技術、基因轉植技術以及幹細胞研究等技術之創新而去製造物種間的混合嵌合體,已不是技術問題。然而物種混合嵌合體卻是引發物種的界線混淆之道德問題,導致社會大眾產生疑慮與反對意見。英國「人類受精與胚胎學管理局」於二○○七月一日十一日受理,並於二○○八年一月十七日批准人獸胚胎研究申請,加深人獸分際之諸多倫理和法律更為複雜問題。本論文深入探討與分析台灣目前規定以及將來如何規範這些人獸混合胚胎的研究正當性與可專利性之問題。
英文關鍵詞: ChimerasClonesHuman-animal Hybrid EmbryosEmbryonic Stem CellsOrdre Public or Morality
英文摘要: The "chimeras" come from the greece mythology and the pronoun of hybrids from different species. Due to the technological innovations about the embryology, clones, transgenosis and stem cells research etc., they create chimeras oder hybrids from different species, but are not technological problems. However the chimeras oder hybrids lead to the moral issues from the crossing amd mixing-up of the clear boundaries between different species, and they bring about the doubts and dissents of the people. The Human Fertilisation and Embryology Authority (HFEA) has at 11.01.2007 received two applications from scientific teams of Kings College London and Newcastle University, to carry out research using human cells and animal eggs to produce stem cells. HFEA has too at 17.01.2008 stated on licensing of applications to carry out research using human-animal cytoplasmic hybrid embryos. The receiving and licensing of HFEA for the applications of the Human-animal Hybrid Embryos reinforce the some legal and moral issues from the confused boundaries between the humans and animals. My this dissertation probes into and analyzes the present regulations of the research Legitimacy and patentability about the human-animal hybrid embryos, and in future how they are to be regulated in taiwan.
目  次: 壹、問題提出
貳、嵌合體之現代技術背景
參、案例說明
肆、人獸混合胚胎之研究正當性問題
伍、人獸混合胚胎幹細胞之可專利性問題
陸、代結論—法律與道德衝突之永恆難題
相關法條:
相關判解:
    相關函釋:
    相關論著:
      返回功能列